2021 ASCO Virtual Direct™ Highlights

 

Jacksonville
23:20

2021 ASCO Virtual Direct™ Highlights

ASCO 2021 Q&A Discussion on GI Cancers: Overview of Recent Trials and Updates

FEATURING Samuel Klempner, Louise Connell
  • 18 views
  • August 23, 2021
07:10

2021 ASCO Virtual Direct™ Highlights

2021 ASCO CRC Updates: 1L Pembro vs. Chemo, Maintenance Chemo, 2L and Beyond

FEATURING Louise Connell
  • 58 views
  • August 23, 2021
05:32

2021 ASCO Virtual Direct™ Highlights

ASCO 2021 Highlights on the Upper GI Tract: Summary of Recent Data From Phase II/III Trials

FEATURING Samuel Klempner
  • 13 views
  • August 23, 2021
21:50

2021 ASCO Virtual Direct™ Highlights

ASCO 2021 Q&A Discussion on Lung Cancers: New Findings and Changes in Clinical Practice

FEATURING John Vu, Ibiayi Dagogo-Jack
  • 10 views
  • August 20, 2021
04:45

2021 ASCO Virtual Direct™ Highlights

2021 ASCO Highlights on mNSCLC: Racial Disparities in Molecular Testing, Amivantamab + Lazertinib, Nivo + Ipi + Chemo vs. Chemo Alone, irAEs Analyses

FEATURING Ibiayi Dagogo-Jack
  • 10 views
  • August 20, 2021
07:04

2021 ASCO Virtual Direct™ Highlights

2021 ASCO Updates in Locally Advanced Lung Cancers: Adjuvant Atezolizumab, VATS vs. Open Lobectomy in NSCLC, 2L Vinorelbine in Mesothelioma

FEATURING John Vu
  • 14 views
  • August 20, 2021
21:29

2021 ASCO Virtual Direct™ Highlights

2021 ASCO Q&A Session on Genitourinary Cancers: Key Takeaways From Recent Clinical Trials

FEATURING William Kelly, Joseph Kim
  • 114 views
  • August 20, 2021
  • 1
09:04

2021 ASCO Virtual Direct™ Highlights

ASCO 2021 Highlights on PC: Lu-177-PSMA-617 in mCRPC, Abiraterone Acetate + Prednisone +/- RT for mCSPC, Enzalutamide +/- Ra223, ADT + TAK-700 With ADT + Bicalutamide in Newly Diagnosed mHSPC

FEATURING William Kelly
  • 26 views
  • August 20, 2021
02:28

2021 ASCO Virtual Direct™ Highlights

2021 ASCO Key Takeaways on Kidney & Bladder Cancers: Immuno-oncology, Avelumab in mUC, Adjuvant Pembrolizumab Following Surgery in High-Risk ccRCC

FEATURING Joseph Kim
  • 61 views
  • August 19, 2021
22:32

2021 ASCO Virtual Direct™ Highlights

2021 ASCO Q&A on Practice-Changing Abstracts in Lymphoma and Leukemia

FEATURING Jake Soumerai, Tapan Kadia
  • 12 views
  • August 19, 2021
05:36

2021 ASCO Virtual Direct™ Highlights

2021 ASCO Highlights on Leukemias: Ponatinib in CML, Blinatumomab + Ponatinib in Ph+ ALL, KTE-X19 in R/R B-cell ALL, Acalabrutinib vs. Ibrutinib in CLL, Enasidenib in IDH2-Mutated MDS

FEATURING Tapan Kadia
  • 3 views
  • August 19, 2021
29:05

2021 ASCO Virtual Direct™ Highlights

ASCO 2021 Q&A on Breast Cancer Clinical Data Updates and Impact on Practice Strategies

FEATURING Hatem Soliman, Alvaro Moreno-Aspitia
  • 9 views
  • August 19, 2021
07:07

2021 ASCO Virtual Direct™ Highlights

2021 ASCO Updates on EBC: Olaparib in gBRCA1/2m HER2- Disease, Capecitabine vs. Platinum Chemo for TNBC, Neoadjuvant Trastuzumab/Pertuzumab +/- Taxane for HER2+ BC

FEATURING Hatem Soliman
  • 115 views
  • August 19, 2021
EVENT

Total Health Conferencing

2021 ASCO Virtual Direct™ Highlights Jacksonville

Saturday, July 10, 2021 7 AM - 3 PM
None
  • 96 views
  • April 26, 2021